Altered fractionation radiotherapy in head and neck squamous cell carcinoma

Wei, 2002, Commentary: head and neck carcinomas in the developing world, BMJ, 12, 822 Mohanti, 2007, Analysis of 2167 head and neck cancer patients’ management, treatment compliance and outcomes from a regional cancer centre, Delhi, India, J Laryngol Otol, 121, 49, 10.1017/S0022215106002751 Pignon, 2009, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients, Radiother Oncol, 92, 4, 10.1016/j.radonc.2009.04.014 Vikam, 2003, Cancers of the head and neck region in developing countries, Radiother Oncol, 70, 207 Dubois, 1995 Coutard, 1937, The results and methods of treatment of cancer by radiation, Ann Surg, 106, 584, 10.1097/00000658-193710000-00010 Fu, 2000, A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003, Int J Radiat Oncol Biol Phys, 48, 7, 10.1016/S0360-3016(00)00663-5 Beitler, 2014, Final results of local regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer, Int J Radiat Oncol Biol Phys, 89, 1320, 10.1016/j.ijrobp.2013.12.027 Cummings, 2007, Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer, Radiother Oncol, 85, 7, 10.1016/j.radonc.2007.09.010 Bourhis, 2006, Hyperfractionated or accelerated radiotherapy for head and neck cancer, Lancet, 368, 843, 10.1016/S0140-6736(06)69121-6 Budach, 2006, A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck, BMC Cancer, 6, 28, 10.1186/1471-2407-6-28 Overgaard, 2003, Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial, Lancet, 362, 933, 10.1016/S0140-6736(03)14361-9 Overgaard, 2010, Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial, Lancet Oncol, 11, 503, 10.1016/S1470-2045(10)70072-3 Skladowski, 2000, A randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer-report on 3-year tumour control and normal tissue toxicity, Radiother Oncol, 55, 101, 10.1016/S0167-8140(00)00139-0 Horiot, 1997, Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced Head and neck cancers: results of the EORTC 22851 randomized trial, Radiother Oncol, 44, 111, 10.1016/S0167-8140(97)00079-0 Zackrisson, 2011, Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma – the ARTSCAN study, Radiother Oncol, 100, 41, 10.1016/j.radonc.2010.12.010 Chitapanarux, 2013, Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer, J Radiat Res, 54, 1110, 10.1093/jrr/rrt054 Gupta, 2014, Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: an adjusted indirect comparison meta-analysis, Head Neck Dobrowsky, 2000, Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers, Radiother Oncol, 57, 119, 10.1016/S0167-8140(00)00233-4 Staar, 2001, Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized german trial in advanced head and neck cancer, Int J Radiat Oncol Biol Phys, 50, 1161, 10.1016/S0360-3016(01)01544-9 Garden, 2008, Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99–14), Int J Radiat Oncol Biol Phys, 71, 1351, 10.1016/j.ijrobp.2008.04.006 Rishi, 2013, Comparison of concomitant boost radiotherapy against concurrent chemoradiation in locally advanced oropharyngeal cancers: a phase III randomised trial, Radiother Oncol, 107, 317, 10.1016/j.radonc.2013.05.016 Nguyen-Tan, 2014, Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: long-term report of efficacy and toxicity, J Clin Oncol, 32, 3858, 10.1200/JCO.2014.55.3925 Ang, 2014, Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522, J Clin Oncol, 32, 2940, 10.1200/JCO.2013.53.5633 Ang, 2008, Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes, Oncologist, 13, 899, 10.1634/theoncologist.2007-0157 Awwad, 1992, Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation, Radiother Oncol, 25, 261, 10.1016/0167-8140(92)90245-P Sanguineti, 2005, Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multi center Phase III study, Int J Radiat Oncol Biol Phys, 61, 762, 10.1016/j.ijrobp.2004.07.682 Suwinski, 2008, Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer, Radiother Oncol, 87, 155, 10.1016/j.radonc.2008.02.009 Mohanti, 2004, Short course palliative radiotherapy of 20 Gray in 5 fractions for advanced and incurable head and neck cancer: AIIMS study, Radiother Oncol, 71, 275, 10.1016/j.radonc.2004.03.009 Corry, 2005, The ‘QUAD SHOT’ – a phase II study of palliative radiotherapy for incurable head and neck cancer, Radiother Oncol, 77, 137, 10.1016/j.radonc.2005.10.008 Yamazaki, 2006, Radiotherapy for early glottis carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time, Int J Radiat Oncol Biol Phys, 64, 77, 10.1016/j.ijrobp.2005.06.014 Moon, 2014, A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1–2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study, Radiother Oncol, 110, 98, 10.1016/j.radonc.2013.09.016 Karasawa, 2013, Radiotherapy with fraction size of 2.25Gy in T1–2 laryngeal and hypopharyngeal cancer, J Radiat Res, 54, 684, 10.1093/jrr/rrs134 Onimaru, 2011, Radiotherapy for glottic T1N0 carcinoma with slight hypofractionation and standard overall treatment time: importance of overall treatment time, Jpn J Clin Oncol, 41, 103, 10.1093/jjco/hyq153 Amado, 2013, 3D conformal hypofractionated radical radiotherapy in early glottic cancer, Rep Pract Oncol Radiother, 18, 261, 10.1016/j.rpor.2013.04.034